Company information lookup

TISSUE THERAPIES LIMITED (TIS)

Developing biomedical technologies for wound healing and tissue and cell culture.

On this page you will find:

Delayed share price ASX-Listed Emblem Company details
Company announcements Closing prices
Price history chart Dividends
Exchange Traded Options Warrants & Structured Products
   ASX CFDs

Delayed share price

Prices are delayed by at least 20 minutes. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
TIS 0.205 0% 0.205 0.210 0.210 0.215 0.205 425,173

TISSUE THERAPIES LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code TIS
Securities
Official Listing Date 19 March, 2004
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.tissuetherapies.com
Registered Office Address Level 11, Central Plaza Two, 66 Eagle Street, BRISBANE, QLD, AUSTRALIA, 4000
Head Office Telephone (07) 3839 9938
Head Office Fax (07) 3839 1486
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000
Share Registry Telephone (02) 8280 7454
Directors / Senior Management
Mr Roger Clarke (Chairman)
Dr Steven Mercer (CEO, Director)
Mr Gregory Baynton (Director)
Mr Mel Bridges (Director)
Dr Cherrell Hirst (Director)
Company Secretary Mr Drummond McKenzie
Principal Activities Developing biomedical technologies for wound healing and tissue and cell culture.

TISSUE THERAPIES LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
02/09/2010 asterix Exceptional VitroGro Clinical Results Continue 3 PDF
11/08/2010   Directors Report and Full Year Statutory Accounts 36 PDF
11/08/2010 asterix Appendix 4E Preliminary Final Report 2 PDF
09/08/2010 asterix VitroGro Patent Granted in Japan 1 PDF
23/07/2010 asterix Appendix 4C for Quarter Ended 30 June 2010 5 PDF
13/07/2010 asterix Excellent Clinical Results and Manufacturing Complete 2 PDF
17/06/2010 asterix More Exceptional Clinical Results for VitroGro 3 PDF
16/04/2010 asterix Appendix 4C - quarterly 5 PDF
15/03/2010   Investor Update March 2010 2 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
03 Sep 2010 0.205 5.13% 0.205 0.190 504,500
02 Sep 2010 0.195 8.33% 0.195 0.185 198,135
01 Sep 2010 0.180 -5.26% 0.190 0.180 53,000
31 Aug 2010 0.190 0% 0.190 0.190 99,522
30 Aug 2010 0.190 2.7% 0.190 0.185 106,548

* Volume of shares shown represents only those shares traded on ASX.

TISSUE THERAPIES LIMITED price history chart

ASX excludes all liability arising out of any inaccuracies in this chart, except where liability is made non-excludable by legislation. Chart values may be adjusted for changes in a company's capital structure or to link historical values that represent the company's primary equity security. Explanation of chart terms.



Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security TIS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No options are available over the security TIS

Warrants & Structured Products

No warrants & Structured Products are available over the security TIS

ASX CFDs

No Contracts For Differences are available over the security TIS